Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience

被引：0
|
作者：
Ali, S. [1 ]
Basit, A. [1 ]
Kazmi, A. S. [1 ]
Badar, F. [1 ]
Sidhu, A. [1 ]
Hameed, A. [1 ]
机构：
[1] Shaukat Khanum Mem Canc Hosp & Reserch Ctr SKM, Dept Med Oncol, Lahore, Pakistan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw375.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
932P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Preliminary Efficacy and Safety of Brentuximab Vedotin and AVD Chemotherapy Followed by Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (08) : 4 - 5
  • [42] INTENSIFIED CHEMOTHERAPY BEACOPP ESCALATED FOLLOWED BY ABVD AND INVOLVED FIELD RADIOTHERAPY IN PATIENTS WITH EARLY UNFAVORABLE HODGKIN'S LYMPHOMA: SINGLE CENTER EXPERIENCE
    Sykorova, A.
    Stepankova, P.
    Belada, D.
    Klimes, D.
    Smolej, L.
    Maly, J.
    ANNALS OF ONCOLOGY, 2011, 22 : 239 - 239
  • [43] Treatment Outcomes for Radiotherapy Alone are Comparable With Neoadjuvant Chemotherapy Followed by Radiotherapy in Early-Stage Nasopharyngeal Carcinoma
    Song, Chang Hoon
    Wu, Hong-Gyun
    Heo, Dae Seog
    Kim, Kwang Hyun
    Sung, Myung-Whun
    Park, Charn Il
    LARYNGOSCOPE, 2008, 118 (04): : 663 - 670
  • [44] Fifteen-Year Experience of a Single Institution: Outcomes for Early-Stage Hodgkins Lymphoma Comparing Chemotherapy Alone Versus Combined Modality Therapy
    Qian, Joshua Y.
    Amin, Radhesh
    Ali, Humzah
    Cao, Yichun
    Switchenko, Jeffrey M.
    Rashid, Arif S.
    Allen, Pamela B.
    Hanasoge, Sheela
    Khan, Mohammad K.
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (12)
  • [45] Early-stage classical Hodgkin lymphoma in children and adolescents: when can radiotherapy be safely omitted?
    Mascarin, Maurizio
    LANCET ONCOLOGY, 2023, 24 (03): : 196 - 197
  • [46] Consolidating Involved Field Radiotherapy Prevents Early and Local Recurrences in Early Stage Hodgkin Lymphoma
    Baues, C.
    Goergen, H.
    Fuchs, M.
    Kobe, C.
    Dietlein, M.
    Rosenbrock, J.
    Celik, E.
    Eich, H. T. T.
    Kriz, J.
    Semrau, R.
    Borchmann, P.
    Engert, A.
    Marnitz, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S32 - S33
  • [47] Elderly patients with Hodgkin Lymphoma: Extended-field radiotherapy versus involved-field radiotherapy after chemotherapy
    Eich, H. T.
    Klimm, B.
    Kriz, J.
    Haverkamp, H.
    Zimmermann, C.
    Engert, A.
    Mueller, R-P
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 27 - 27
  • [48] Comparison of Involved Field-versus Involved Node-Radiotherapy for Patients with early-stage Hodgkin Lymphoma: what is the patients profit
    Eich, H. T.
    Zimmermann, C.
    Hilger, T.
    Kriz, J.
    Engert, A.
    Mueller, R.-P.
    ONKOLOGIE, 2010, 33 : 139 - 139
  • [49] Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin Lymphoma
    Metzger, Monika L.
    Weinstein, Howard J.
    Hudson, Melissa M.
    Billett, Amy L.
    Larsen, Eric C.
    Friedmann, Alison
    Howard, Scott C.
    Donaldson, Sarah S.
    Krasin, Matthew J.
    Kun, Larry E.
    Marcus, Karen J.
    Yock, Torunn I.
    Tarbell, Nancy
    Billups, Catherine A.
    Wu, Jianrong
    Link, Michael P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (24): : 2609 - 2616
  • [50] Can Low-Risk, Early-Stage Patients with Hodgkin Lymphoma Be Spared Radiotherapy?
    Gregory M. Cote
    George P. Canellos
    Current Hematologic Malignancy Reports, 2011, 6
12345